Section I ยท Last reviewed 2026-05-16
The Dutch Protocol
What the protocol formally claims to be, where it actually comes from, and which assumptions have never been tested.
What is documented here
This section describes the Dutch Protocol as formulated by the original VUmc authors: a phased pathway of puberty suppression, cross-sex hormones and surgery in adolescents. We describe it not to endorse it, but to show on which assumptions a globally applied treatment rests. The independent evaluations since 2020 (Cass, SBU, NICE, COHERE, Ukom) found the evidence under these assumptions weak; NICE rated it "very low certainty" for puberty blockers (source), and the Dutch Health Council (2026) rates it low to very low (source). Read each claim below alongside the assessment in /evaluations/ and /debate/scientific-criticism/.
Subpages
- Definition โ what the protocol formally claims to be
- Origins โ Cohen-Kettenis, Utrecht 1987, 1998 case, 2011 VUmc study
- The three phases โ psychological evaluation, puberty suppression, cross-sex hormones
- Age criteria โ Tanner stages, age limits originally and loosened in the rollout
- Inclusion criteria โ the original conditions of the Dutch Protocol and how later practice widened them
- Exclusion criteria โ psychiatric comorbidity and autism; later applied to a broader group
- Informed consent โ how consent is arranged under Dutch law; why critics question the informed-consent process
- Follow-up โ measurement points up to at least 1 year after surgery; long-term data are lacking
- Changes over time โ how the original was stretched
- Current status Netherlands โ the Netherlands continues care while the Quality Standard is being revised
Related
- Scientific basis โ the evidence base.
- Evaluations โ what independent evaluators conclude.
- International comparison โ all countries in table form.
- For parents ยท For clinicians.
- People index ยท Timeline.
- FAQ ยท Glossary